GlassScriptPhysician profile
Eric Brian Russell
NPI 1033198510
$4,120.03
in general payments reported to CMS, 2019-2025
16 companies · $368 in 2025
The $368 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $393 · 2020: $333 · 2021: $633 · 2022: $763 · 2023: $827 · 2024: $802 · 2025: $368.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,914 · Education: $82.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,914.07 |
| Education | $82.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $1,008.93 | 2019-2025 | Tremfya |
| Abbvie INC. | $709.10 | 2019-2024 | Skyrizi, Rinvoq |
| Sun Pharmaceutical Industries INC. | $632.42 | 2020-2025 | Ilumya |
| Ucb, INC. | $389.72 | 2021-2025 | Bimzelx, Cimzia |
| Pfizer INC. | $370.02 | 2019-2024 | |
| Lilly USA, LLC | $368.97 | 2019-2024 | Taltz, Olumiant |
| E.R. Squibb & Sons, L.L.C. | $210.37 | 2023-2024 | Sotyktu |
| Leo Pharma INC. | $104.45 | 2022-2025 | Adbry, Anzupgo |
| Regeneron Healthcare Solutions, INC. | $69.29 | 2021-2025 | Libtayo |
| Genzyme Corporation | $67.04 | 2019-2025 | |
| Galderma Laboratories, L.P. | $60.76 | 2019-2025 | Aklief, Nemluvio |
| Kerecis Limited | $45.81 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Dermavant Sciences, INC. | $31.78 | 2022-2023 | Vtama |
| Aclaris Therapeutics, INC. | $20.46 | 2019 | |
| Janssen Scientific Affairs, LLC | $17.11 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $13.80 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Russell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.